Some Characteristics of the Psychoemotional Aspect in Children and Adolescents (5–18 years old) with Migraine
https://doi.org/10.31550/1727-2378-2022-21-7-28-33
Abstract
Study Objective: To identify the features of psychoemotional characteristics of children and adolescents with migraine.
Study Design: Comparative study. Materials and methods. We have examined 160 patients: preschool children (5–6 years old), primary school-aged children (7–10 years old), secondary school-aged children (11–14 years old), and high school-aged children (15–18 years old). Patients with verified migraine (G43.0, 43.1, 43.3, 43.8 as per ICD-10) were included into study group (I , n = 80), patients without migraine comprised group (controls) II, n = 80). Questionnaires were used to find out complaints, collect medical and family history, history of early development of the child; children underwent standard neurological and somatic tests and a comprehensive clinical and laboratory examination
Study Results. 80.0% of subjects who complained of headache said their headache was severe and either markedly (1/3 of cases), or significantly (2/3 of cases) affecting their daily life. Patients in group I more frequently had mild situational or neurotic depression vs. group II (18.7% vs. 13.5%) and situational or personal anxiety (28.8% vs. 11.4% and 33.8% vs. 11.4%, respectively).
Conclusion. The specific features of the psychoemotional state of children and adults with migraine require psychological support, especially in depression and anxiety.
About the Authors
P. V. Zhmyleva
I.M. Sechenov First Moscow State Medical University (Sechenov University) (a Federal Government Autonomous Educational Institution of Higher Education), Russian Federation Ministry of Health; Tambov Regional Children Clinical Hospital
Russian Federation
Russian Federation
8 Trubetskaya St., Bldg. 2, Moscow, 119991
80 Ryleeva Str., Tambov, 392000
N. A. Kovalchuk
I.M. Sechenov First Moscow State Medical University (Sechenov University) (a Federal Government Autonomous Educational Institution of Higher Education), Russian Federation Ministry of Health
Russian Federation
Russian Federation
8 Trubetskaya St., Bldg. 2, Moscow, 119991
G. R. Tabeeva
I.M. Sechenov First Moscow State Medical University (Sechenov University) (a Federal Government Autonomous Educational Institution of Higher Education), Russian Federation Ministry of Health
Russian Federation
Russian Federation
8 Trubetskaya St., Bldg. 2, Moscow, 119991
References
1. Abu-Arafeh I., Razak S., Sivaraman B., Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev. Med. Child Neurol. 2010; 52(12): 1088 97. DOI: 10.1111/j.1469-8749.2010.03793.x
2. Rocha-Filho P.A.S, Gherpelli J.L.D. Premonitory and Accompanying Symptoms in Childhood Migraine. Curr. Pain Headache Rep. 2022; 26(2): 151–63. DOI: 10.1007/s11916-022-01015-z
3. Hershey A.D. Current approaches to the diagnosis and management of paediatric migraine. Lancet Neurol. 2010; 9(2): 190–204. DOI: 10.1016/S1474-4422(09)70303-5
4. Lipton R.B., Manack A., Ricci J.A., Chee E. et al. Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). Headache. 2018; 51(5): 693–706. DOI: 10.1111/j.1526-4610.2011.01885.x. Epub. 2011 Apr. 26.
5. Yaghini O., Badihian N., Badihian S. The efficacy of topiramate in benign paroxysmal torticollis of infancy: report of four cases. Pediatrics. 2016; 137(4): e20150868. DOI: 10.1542/peds.2015-0868
6. Millichap J.G., Yee M.M. The diet factor in pediatric and adolescent migraine. Pediatr. Neurol. 2003; 28(1): 9–15. DOI: 10.1016/s0887 8994(02)00466-6
7. Raucci U., Boni A., Evangelisti M., Vecchia N.D. et al. Lifestyle modifications to help prevent headache at a developmental age. Front. Neurol. 2021; 11: 618375. DOI: 10.3389/fneur.2020.618375
8. Khorsha F., Mirzababaei A., Togha M., Mirzaei K. Association of drinking water and migraine headache severity. J. Clin. Neurosci. 2020; 77: 81–4. DOI: 10.1016/j.jocn.2020.05.034
9. Gelfand A.A., Irwin S.L. Lifestyle advice for pediatric migraine: blaming the patient, or evidence based? Semin. Neurol. 2020; 40(3): 277–85. DOI: 10.1055/s-0040-1708868
10. Knestrick K.E., Gibler R.C., Reidy B.L., Powers S.W. Psychological interventions for pediatric headache disorders: a 2021 update on research progress and needs. Curr. Pain Headache Rep. 2022; 26(1): 85–91. DOI: 10.1007/s11916-022-01007-z
11. Grazzi L., Grignani E., Raggi A., Rizzoli P. et al. Effect of a mindfulness-based intervention for chronic migraine and high frequency episodic migraine in adolescents: a pilot single-arm open-label study. Int. J. Environ. Res. Public Health. 2021; 18(22): 11739. DOI: 10.3390/ijerph182211739
12. Gibler R.C., Knestrick K.E., Reidy B.L., Lax D.N. et al. Management of chronic migraine in children and adolescents: where are we in 2022? Pediatric Health Med. Ther. 2022; 13: 309–23. DOI: 10.2147/PHMT.S334744
13. Oskoui M., Pringsheim T., Managan Y.H., Potrebic S. et al. Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019; 93(11): 487–99. DOI: 10.1212/WNL.0000000000008095
14. Loh N.R., Whitehouse W.P., Howells R. What is new in migraine management in children and young people? Arch. Dis. Child. 2022; archdischild-2021-322373. DOI: 10.1136/archdischild-2021-322373
15. Talai A., Heilbrunn B. Ondansetron for acute migraine in the pediatric emergency department. Pediatr. Neurol. 2020; 103: 52–6. DOI: 10.1016/j.pediatrneurol.2019.06.011. Epub. 2019 Jul. 5.
16. VanderPluym J., Gautreaux J., Burch R., Whitaker E. et al. Evidence regarding medication overuse headache in children and adolescents: Protocol for a systematic review. Headache. 2020; 60(1): 171–7. DOI: 10.1111/head.13726
17. Ziplow J. The psychiatric comorbidities of migraine in children and adolescents. Curr. Pain Headache Rep. 2021; 25(11): 69. DOI: 10.1007/s11916-021-00983-y
18. Stafstrom C.E., Rostasy K., Minster A. The usefulness of children's drawings in the diagnosis of headache. Pediatrics. 2002; 109(3): 460 72. DOI: 10.1542/peds.109.3.460
19. Stafstrom C.E., Goldenholz S.R., Dulli D.A. Serial headache drawings by children with migraine: correlation with clinical headache status. J. Child Neurol. 2005; 20(10): 809–13. DOI: 10.1177/08830738050200100501
20. Mazzotta S., Pavlidis E., Cordori C., Spagnoli C. et al. Children's headache: drawings in the diagnostic work up. Neuropediatrics. 2015; 46(4): 261 8. DOI: 10.1055/s-0035-1550147
21. Davidsson O.B., Rostgaard K., Hjalgrim L.L., Chalmer M.A. et al. Childhood cancer confers increased risk of migraine — A Danish Nationwide Register Study. Cancer Epidemiol. 2022; 81: 102278. DOI: 10.1016/j.canep.2022.102278
22. Mosquera M.S., Martino G.H. Children and adolescent's drawing for the diagnosis of migraine. Arch. Argent. Pediatr. 2008; 106(1): 11–8. 23. Bergmans R.S., Smith J. Associations of mental health and chronic physical illness durig childhood with major depression in later life. Aging Ment. Health. 2022; 26(9): 1813–20. DOI: 10.1080/13607863.2021.1958143. Epub. 2021 Aug. 6.
23. Newman L.C., Newman E.B. Rebound abdominal pain: noncephalic pain in abdominal migraine is exacerbated by medication overuse. Headache. 2008; 48(6): 959–61. DOI: 10.1111/j.1526-4610.2008.01126.x
24. Lagman-Bartolome A.M., Lay C. Pediatric migraine variants: a review of epidemiology, diagnosis, treatment, and outcome. Curr. Neurol. Neurosci. Rep. 2015; 15(6): 34. DOI: 10.1007/s11910-015-0551-3
25. Greene K., Irwin S.L., Gelfand A.A. Pediatric Migraine: An Update. Neurol. Clin. 2019; 37(4): 815–33. DOI: 10.1016/j.ncl.2019.07.009
26. Karelin A.A. Great encyclopaedia of psychological tests. M.: Eksmo; 2007: 34–5. (in Russian)
27. Førland-Schill A., Berring-Uldum A., Debes N.M. Migraine pathophysiology in children and adolescents: A review of the literature. J. Child Neurol. 2022; 37(7): 642–51. DOI: 10.1177/08830738221100888
28. Liu A. Headaches. Pediatr. Ann. 2021; 50(12): e479-e485. DOI: 10.3928/19382359-20211112-01
29. Wöber-Bingöl C. Epidemiology of migraine and headache in children and adolescents. Curr. Pain Headache Rep. 2013; 17(6): 341. DOI: 10.1007/s11916-013-0341-z
30. Kelly M., Strelzik J., Langdon R., DiSabella M. Pediatric headache: overview. Curr. Opin. Pediatr. 2018; 30(6): 748–54. DOI: 10.1097/MOP.0000000000000688
31. Swartwood S., Pham K., Candee M.S. Pediatric migraine phenomena and variants: don’t let them go over your head. Curr. Pain Headache Rep. 2020; 24(9): 47. DOI: 10.1007/s11916-020-00879-3
32. Taga A., Russo M., Genovese A., Paglia M.V. et al. Pediatric migraine with aura in an Italian case series. Neurol. Sci. 2017; 38 (suppl. 1): 185–7. DOI: 10.1007/s10072-017-2943-4
33. You D.S., Albu S., Lisenbardt H., Meagher M.W. Cumulative childhood adversity as a risk factor for common chronic pain conditions in young adults. Pain Med. 2019; 20(3): 486–94. DOI: 10.1093/pm/pny106
34. Dao J.M., Qubty W. Headache diagnosis in children and adolescents. Curr. Pain Headache Rep. 2018; 22(3): 17. DOI: 10.1007/s11916-018-0675-7
35. Woldeamanuel Y.W., Cowan R.P. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community based studies involving 6 million participants. J. Neurol. Sci. 2017; 372: 307–15. DOI: 10.1016/j.jns.2016.11.071. Epub. 2016 Dec. 3.
36. Yusoff R., Janor R.M. Generation of an interval metric scale to measure attitude. SAGE Open. 2014; 4(1): 1–16. DOI: 10.1177/ 2158244013516768
37. Kuhlmann T., Dantlgraber M., Reips U.-D. Investigating measurement equivalence of visual analogue scales and Likert-type scales in Internet based personality questionnaires. Behav. Res. Methods. 2017; 49(6): 2173–81. DOI: 10.3758/s13428-016-0850-x
38. Minen M.T., De Dhaem O.B., Van Diest A.K., Powers S. et al. Migraine and its psychiatric comorbidities. J. Neurol. Neurosurg. Psychiatry. 2017; 87(7): 741–9. DOI: 10.1136/jnnp-2015-312233
39. Ziplow J. The psychiatric comorbidities of migraine in children and adolescents. Curr. Pain Headache Rep. 2021; 25(11): 69. DOI: 10.1007/s11916-021-00983-y
40. Gelfand A.A. Psychiatric comorbidity and paediatric migraine: examining the evidence. Curr. Opin. Neurol. 2017; 28(3): 261–4. DOI: 10.1097/WCO.0000000000000192
41. O'Brien H.L., Slater S.K. Comorbid psychological conditions in pediatric headache. Semin. Pediatr. Neurol. 2016; 23(1): 68–70. DOI: 10.1016/j.spen.2016.01.002
42. Oskoui M., Pringsheim T., Billinghurst L., Potrebic S. et al. Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019; 93(11): 500–9. DOI: 10.1212/WNL.0000000000008105
43. Kroon Van Diest A.M., Powers S.W. Cognitive behavioral therapy for pediatric headache and migraine: why to prescribe and what new research is critical for advancing integrated biobehavioral care. Headache. 2019; 59(2): 289–97. DOI: 10.1111/head.13438. Epub. 2018 Nov. 16.
44. Takeshita M., Ishida Y., Kano K., Go S. et al. Primary stabbing headache in children and adolescents. Indian J. Pediatr. 2021; 88(11): 1160. DOI: 10.1007/s12098-021-03889-0
45. Nguyen E., Inger H., Jordan C., Rogers D. Ocular causes for headache. Semin. Pediatr. Neurol. 2021; 40: 100925. DOI: 10.1016/j.spen.2021.100925
Review
For citations:
Zhmyleva P.V., Kovalchuk N.A., Tabeeva G.R. Some Characteristics of the Psychoemotional Aspect in Children and Adolescents (5–18 years old) with Migraine. Title. 2022;21(7):28-33. (In Russ.) https://doi.org/10.31550/1727-2378-2022-21-7-28-33
Views:
30
Email this article 